Summary of Significant Accounting Policies (Tables)

3 Months Ended

Sep. 30, 2016

Summary of Significant Accounting Policies

Schedule of the Company's net sales by medical indication

(In thousands)	Three Months Ended September 30,
Medical Indication	2016		2015
Antibiotic	$	3,780	$	2,727
Anti Psychosis	17,320		2,742
Cardiovascular	12,694		8,303
Central Nervous System	10,350		—
Gallstone	12,883		19,972
Gastrointestinal	18,052		76
Glaucoma	5,783		6,822
Migraine	7,160		5,542
Muscle Relaxant	3,532		1,661
Obesity	835		979
Pain Management	6,608		8,133
Respiratory	2,213		—
Thyroid Deficiency	39,838		41,102
Urinary	5,101		215
Other	10,347		8,159
Contract manufacturing revenue	5,063		—
Total	$	161,559	$	106,433

Summary of products which accounted for at least 10% of net sales

	2016		2015
Product 1	25	%	39	%
Product 2	8	%	19	%

Summary of customers which accounted for at least 10% of net sales

	2016		2015
Customer A	28	%	28	%
Customer B	20	%	12	%